QUICK SEARCH:

[advanced]

	Author:		Keyword(s):

Home Help Feedback Subscriptions Archive Search Table of Contents

	Help viewing high resolution images
	Return to article

(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 7. Fetal liver development requires hematopoietic cells but not c-Myc. (A) c-Myc expression in the fetal liver of E10.5 control (upper panel; higher magnification is shown in the right panel) and Sox2Cre;c-myc^flox^/^flox (bottom left) embryos. The broken line outlines the fetal liver. c-Myc is expressed in hepatoblasts (arrows) and blood cells (arrowheads). (B) Hematoxylin and Eosin (H&E) staining of control and Sox2Cre;c-myc^flox^/^flox fetal livers at E10.5. The top panels show low magnification, whereas the bottom panels show a high magnification. (C) HNF4 ${alpha}$ expression in control and Sox2Cre;c-myc^flox^/^flox embryos at E11.0. (D) H&E staining (top panels) and HNF4 ${alpha}$ expression (bottom panels) in E11.0 control and Tie2Cre;c-myc^flox^/^flox embryos. (E) Model illustrating the different direct roles for c-Myc in the midgestation embryo and the placenta. First, c-Myc is required to generate a functional embryonic placenta. Second, only in the presence of a normal placenta are the direct roles of c-Myc in the embryo proper revealed. Primitive YS erythropoiesis is drastically decreased. Although definitive AGM derived HSCs are generated in normal numbers, these mutant HSCs are non-functional and only very few hematopoietic cells (of primitive and definitive origin) reach the fetal liver, which as a consequence remains hypoplastic and fails to expand. All other organs and tissues proliferate and develop normally.

Return to article